Lupin launches Glucagon for Injection USP, 1mg/Vial in US
Glucagon is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus
Glucagon is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
The company has confirmed that the deceased are 39
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Around 100 million people live with COPD in China, accounting for almost 25% of all COPD cases globally
Emcure and Dhoni, through a video, urge everyone to be aware about symptoms of stroke and educate at least one person for identification of stroke and spread its awareness
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Subscribe To Our Newsletter & Stay Updated